If a state screening program found your cancer, a special pathway may connect you to Medicaid coverage for treatment. This guide explains how the connection works, step by step.
The Breast and Cervical Cancer Treatment Program: How It Connects Patients to Medicaid Read More »
Medicare’s parts divide hospital, medical, and drug coverage in ways that matter during cancer treatment. This guide explains each part in plain language and the choices worth checking.
Medicare and Breast Cancer: What New Patients Should Know Read More »
Medicaid is state-run coverage that can pay for much of your breast cancer treatment if you qualify. This guide explains eligibility pathways, what is generally covered, and how to apply.
Medicaid and Breast Cancer: Coverage Basics Explained Read More »
If a medicine copay is hard to afford, assistance programs may help. This guide compares charitable foundation grants with manufacturer copay programs and explains how enrollment usually works.
Copay Assistance for Breast Cancer Medicines: How These Programs Work Read More »
From national charities to local funds, nonprofits help with medicine costs, rent, utilities, and rides during treatment. This guide shows where to look and how to apply without wasting energy.
Nonprofit Financial Assistance for Breast Cancer Patients: Where to Look Read More »
Charity care is a hospital’s own financial assistance program, and it can reduce or forgive bills for patients who qualify. Here is how to find the policy, apply, and follow up if the first answer is no.
Hospital Charity Care for Breast Cancer Patients: What It Is and How to Ask Read More »
You can get breast cancer treatment without insurance. This guide explains charity care, Medicaid pathways, nonprofit grants, and the first conversations to have so care and payment planning move together.
Breast Cancer Treatment Without Insurance: How to Get Care and Help Paying Read More »
HER2-positive means extra HER2 protein was found; triple-negative means all three receptor tests came back negative. This guide compares the two labels and what each one means for the planning conversation.
Triple-Negative vs HER2-Positive Breast Cancer: How They Differ Read More »
Two words on a pathology report carry a lot of weight: in situ and invasive. This guide explains what each one means, why invasive is not the same as metastatic, and how the words connect to stage.
In Situ vs Invasive Breast Cancer: What Those Words Mean Read More »
DCIS is treated as stage 0 cancer in a milk duct, while LCIS is usually a sign of higher future risk rather than a cancer itself. This guide explains how the two findings differ and why follow-up differs too.
DCIS vs LCIS: How These Two Findings Differ Read More »
Invasive ductal and invasive lobular carcinoma differ in where they begin and how their cells grow — a clumped mass versus single-file lines. This guide compares them side by side in plain language.
Invasive Ductal vs Invasive Lobular Carcinoma: The Key Differences Read More »
DCIS and invasive ductal carcinoma both start in a milk duct. This comparison explains the one step that separates them — crossing the duct wall — and how it changes the conversation with your care team.
DCIS vs Invasive Ductal Carcinoma: What Changes When Cancer Is No Longer In Situ Read More »